Peptide Therapy for Inflammation: A New Solution BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Thinking about trying BPC 157? Read this first. While often marketed as a healing peptide BPC 157 is not FDA approved and not pharmacy grade meaning most versions sold online are unregulated, contaminated BPC 157 10mg 5 Vials Us Chem Labs